| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 365 | 378 | 409 | 400 | 432 | 455 | 492 | 459 | 489 | 526 | 565 | 558 | 653 | 655 | 714 | 735 | 776 | 782 | 829 | 791 | 750 | 398 | 611 | 755 | 846 | 867 | 952 | 967 | 951 | 1,041 | 1,173 | 1,140 | 1,236 | 1,249 | 1,324 | 1,222 | 1,273 | 1,364 | 1,424 | 1,353 | 1,503 |
| Expenses | 326 | 344 | 360 | 358 | 392 | 402 | 426 | 406 | 425 | 473 | 502 | 502 | 597 | 607 | 640 | 657 | 676 | 675 | 702 | 684 | 659 | 486 | 575 | 648 | 698 | 728 | 774 | 787 | 768 | 842 | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,037 | 1,092 | 1,028 | 1,126 |
| EBITDA | 39 | 34 | 49 | 42 | 40 | 54 | 66 | 53 | 64 | 53 | 63 | 56 | 56 | 49 | 74 | 79 | 101 | 107 | 127 | 107 | 92 | -87 | 36 | 107 | 148 | 139 | 179 | 180 | 182 | 200 | 275 | 266 | 290 | 286 | 327 | 297 | 318 | 327 | 332 | 325 | 377 |
| Operating Profit % | 10 % | 8 % | 11 % | 10 % | 8 % | 11 % | 13 % | 11 % | 12 % | 9 % | 10 % | 9 % | 8 % | 7 % | 10 % | 10 % | 12 % | 13 % | 15 % | 13 % | 11 % | -23 % | 4 % | 14 % | 17 % | 15 % | 18 % | 18 % | 18 % | 19 % | 21 % | 23 % | 23 % | 22 % | 24 % | 23 % | 23 % | 23 % | 22 % | 23 % | 24 % |
| Depreciation | 19 | 18 | 18 | 19 | 21 | 19 | 20 | 20 | 21 | 22 | 29 | 24 | 26 | 33 | 34 | 35 | 36 | 41 | 43 | 46 | 55 | 46 | 46 | 47 | 45 | 45 | 46 | 46 | 47 | 48 | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 62 | 65 | 70 | 83 |
| Interest | 12 | 9 | 8 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 8 | 8 | 21 | 17 | 18 | 18 | 18 | 22 | 22 | 21 | 21 | 20 | 19 | 19 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 |
| Profit Before Tax | 10 | 10 | 26 | 20 | 13 | 29 | 41 | 28 | 37 | 21 | 26 | 24 | 9 | -1 | 22 | 26 | 47 | 43 | 62 | 40 | 16 | -153 | -30 | 42 | 85 | 77 | 116 | 117 | 119 | 137 | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 232 | 232 | 219 | 254 |
| Tax | 11 | 11 | 16 | 14 | 8 | 12 | 15 | 11 | 15 | 10 | 10 | 10 | -1 | 3 | 8 | 13 | 10 | 13 | 17 | 9 | 4 | -34 | -26 | 1 | 17 | 1 | 17 | 20 | 50 | 27 | 42 | 36 | 40 | 22 | 22 | 21 | 34 | 30 | 33 | 26 | 57 |
| Net Profit | -1 | -1 | 10 | 6 | 5 | 17 | 27 | 17 | 22 | 11 | 17 | 14 | 10 | -4 | 14 | 13 | 37 | 30 | 45 | 31 | 12 | -120 | -3 | 41 | 68 | 76 | 99 | 98 | 69 | 111 | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 |
| EPS in ₹ | 0.00 | -0.03 | 0.52 | 0.29 | 0.25 | 0.85 | 1.31 | 0.84 | 1.10 | 0.54 | 0.82 | 0.70 | 0.48 | -0.21 | 0.67 | 0.63 | 1.83 | 1.49 | 2.23 | 1.55 | 0.59 | -5.90 | -0.17 | 2.01 | 3.35 | 3.75 | 4.89 | 4.80 | 3.40 | 5.45 | 8.31 | 7.57 | 8.53 | 9.06 | 11.16 | 9.26 | 9.39 | 9.92 | 9.78 | 9.50 | 9.71 |
Narayana Hrudayalaya
1,758.90
+34.60
(2.01%)
There are 2 new updates from the company18 hours ago
View
Market Cap
35,945.02 Cr
EPS
38.86
PE Ratio
44.21
Dividend Yield
0.26 %
Industry
Healthcare Services52 Week High
1,871.60
52 Week Low
1,080.00
PB Ratio
9.71
Debt to Equity
0.50
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
Company News
View All News
Narayana Hrudayalaya Reports Q4 Results and Dividend5 days ago
Narayana Hrudayalaya has announced its quarterly results and dividend. The company's Q4 EBITDA increased to 3.85 billion rupees from 3.14 billion rupees year-over-year. The EBITDA margin improved to 26.07% from 25.26% in the same period. Additionally, the company has recommended a dividend of 4.5 rupees per equity share.
Narayana Hrudayalaya Reports Q4 Financial Results5 days ago
Narayana Hrudayalaya announced its Q4 consolidated net profit of 1.97 billion rupees, compared to 1.91 billion rupees year-over-year and 1.92 billion rupees quarter-over-quarter. The company's Q4 revenue increased to 14.7 billion rupees from 12.8 billion rupees in the same quarter last year.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,139.60 | #1 1,10,785.31 | 98.86 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 51.53 | |
6,933.00 | 99,685.90 | 76.28 | #1 19,165.50 | 14.74 | 917 | 49.14 | 50.68 | |
715.10 | 53,987.06 | 63.40 | 6,931.20 | 8.99 | 645 | -7.43 | 58.47 | |
1,758.90 | #4 35,945.02 | #2 44.21 | #4 5,093.40 | #8 10.96 | #3 790 | #7 3.41 | 45.69 | |
1,197.40 | 32,160.65 | 62.62 | 2,759.20 | #1 25.09 | 326 | -20.35 | 49.96 | |
540.90 | 27,018.66 | 73.01 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 52.05 | |
650.00 | 26,009.03 | 69.19 | 2,511.20 | 12.94 | 336 | 48.39 | 51.21 | |
5,890.00 | 14,925.87 | #1 31.63 | 599.90 | 11.69 | 58 | 4.79 | 57.85 | |
1,398.00 | 14,196.92 | 58.71 | 1,334.00 | 10.76 | 218 | 10.57 | 57.52 | |
1,443.00 | 9,461.18 | 49.01 | 1,095.50 | 21.32 | 177 | -0.88 | 49.82 |
Forecast
Actual
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Fixed Assets | 913 | 1,055 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 |
| Current Assets | 260 | 286 | 302 | 479 | 527 | 586 | 665 | 909 | 1,294 | 1,946 |
| Capital Work in Progress | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 |
| Investments | 0 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 |
| Other Assets | 437 | 401 | 416 | 644 | 725 | 701 | 669 | 951 | 1,315 | 1,615 |
| Total Liabilities | 1,370 | 1,556 | 1,647 | 2,536 | 2,637 | 2,891 | 2,770 | 3,131 | 4,162 | 5,625 |
| Current Liabilities | 343 | 315 | 323 | 510 | 510 | 602 | 703 | 780 | 987 | 1,110 |
| Non Current Liabilities | 258 | 365 | 361 | 989 | 1,045 | 1,153 | 946 | 861 | 1,042 | 1,629 |
| Total Equity | 769 | 876 | 963 | 1,036 | 1,082 | 1,137 | 1,121 | 1,489 | 2,132 | 2,885 |
| Reserve & Surplus | 568 | 674 | 761 | 833 | 878 | 933 | 917 | 1,286 | 1,928 | 2,681 |
| Share Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 8 | -2 | 59 | -4 | 97 |
| Investing Activities | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 |
| Operating Activities | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 |
| Financing Activities | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 489 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % | 63.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 11.60 % | 0.00 % | 10.91 % | 10.01 % | 9.68 % | 9.44 % | 9.66 % |
| DIIs | 14.80 % | 15.55 % | 16.15 % | 14.61 % | 13.76 % | 13.43 % | 16.18 % | 14.58 % | 14.14 % | 11.95 % | 10.89 % | 9.46 % | 9.51 % | 8.23 % | 7.90 % | 8.69 % | 8.52 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 4.64 % | 4.97 % | 4.85 % | 5.11 % | 5.92 % | 6.87 % | 5.86 % | 6.93 % | 7.10 % | 7.99 % | 8.46 % | 9.04 % | 10.00 % | 11.68 % | 12.13 % | 11.58 % | 11.47 % |
| Others | 16.71 % | 15.63 % | 15.14 % | 16.43 % | 16.46 % | 15.85 % | 14.11 % | 14.64 % | 14.90 % | 16.20 % | 5.20 % | 17.65 % | 5.73 % | 6.23 % | 6.43 % | 6.43 % | 6.50 % |
| No of Share Holders | 0 | 36,360 | 44,526 | 43,565 | 43,807 | 52,747 | 65,173 | 68,130 | 75,370 | 86,631 | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 | 1,85,787 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 | 1 | 2.5 | 4 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.4 | 0.25 | 0.00 | 0.13 | 0.19 | 0.24 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Aug 2025 |  Annual General Meeting | NA | 29 Aug 2025 | 1,724.30 | 1,722.85 |
| 23 May 2025 |  Quarterly Result Announcement | NA | 23 May 2025 | 1,790.70 | 1,724.30 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 1,372.70 | 1,329.00 |
| 31 Oct 2024 | Quarterly Result Announcement | NA | 31 Oct 2024 | 1,236.20 | 1,222.55 |
| 30 Aug 2024 | Annual General Meeting | NA | 30 Aug 2024 | 1,255.10 | 1,265.50 |
| 02 Aug 2024 |  Dividend | ₹ 4.00 /share | 02 Aug 2024 | 1,255.10 | 1,252.75 |
| 07 Jul 2023 | Dividend | ₹ 2.50 /share | 07 Jul 2023 | 767.85 | 1,012.95 |
| 23 Aug 2022 | Dividend | ₹ 1.00 /share | 22 Aug 2022 | 659.80 | 705.15 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance
18 hours ago
18 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation18 hours ago
18 hours agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
1 day agoClarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.2 days ago
2 days agoClarification sought from Narayana Hrudayalaya Ltd2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days agoGeneral Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.5 days ago
5 days agoGeneral Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.5 days ago
5 days agoShareholders Meeting5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Change in Management5 days ago
5 days agoGeneral Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.5 days ago
5 days agoRecord Date - For Dividend5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoCorporate Action-Board approves Dividend5 days ago
5 days agoBoard Meeting Outcome for Outcome Of The Board Meeting For The Financial Results For The Quarter And Year Ended March 3120255 days ago
5 days agoAudited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 20255 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
10 days agoBoard Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 Dividend And Fund RaisingMay 16, 2025
May 16, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-RevisedApr 30, 2025
Apr 30, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 14, 2025
Apr 14, 2025Rumour verification - Regulation 30(11)Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 05, 2025
Apr 05, 2025Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno Devi Specialty Hospitals Private Limited With Shri Mata Vaishnodevi Charitable SocietyMar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Mar 18, 2025Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Islands A Wholly Owned Subsidiary Of The Company.Mar 08, 2025
Mar 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2025
Mar 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2025
Feb 24, 2025Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2025
Feb 20, 2025Rumour verification - Regulation 30(11)Feb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-AllotmentFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Feb 15, 2025Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The CompanyFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Feb 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025Feb 14, 2025
Feb 14, 2025Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31 2024Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Feb 07, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024Feb 07, 2025
Feb 07, 2025Intimation Regarding Purchase Of Land At BengaluruFeb 05, 2025
Feb 05, 2025Technical Indicators
RSI(14)
Neutral 45.69
ATR(14)
Less Volatile 59.85
STOCH(9,6)
Neutral 22.71
STOCH RSI(14)
Neutral 31.07
MACD(12,26)
Bearish -9.42
ADX(14)
Weak Trend 15.30
UO(9)
Bearish 33.32
ROC(12)
Downtrend And Accelerating -3.18
WillR(14)
Oversold -86.72
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Samco Active Momentum Fund Direct - Growth | 104782 | 2.14% | 2.14% | 2.14% | Apr 2025 | |
 Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth | 0 | 0.00% | -2.05% | 0.00% | Apr 2025 | |
| Samco Special Opportunities Fund Direct - Growth | 23214 | 2.73% | 0.63% | 2.73% | Apr 2025 | |
 Taurus Ethical Fund Direct-Growth | 64759 | 3.99% | 0.59% | 0.82% | Apr 2025 | |
 DSP Multicap Fund Direct - Growth | 82299 | 0.70% | -0.55% | -0.66% | Apr 2025 | |
| DSP Small Cap Direct Plan-Growth | 1005565 | 1.24% | -0.35% | -0.50% | Apr 2025 | |
 Shriram Multi Asset Allocation Fund Direct - Growth | 0 | 0.00% | -0.34% | -0.30% | Apr 2025 | |
| DSP Focus Direct Plan-Growth | 199536 | 1.42% | -0.33% | -1.80% | Apr 2025 | |
| DSP Healthcare Fund Direct - Growth | 248442 | 1.50% | -0.30% | -0.07% | Apr 2025 | |
 Mirae Asset Multicap Fund Direct - Growth | 140712 | 0.71% | -0.18% | -0.23% | Apr 2025 | |
| Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth | 0 | 0.00% | -0.17% | -0.14% | Apr 2025 | |
 Sundaram Business Cycle Fund Direct - Growth | 160489 | 1.68% | -0.12% | -0.40% | Apr 2025 | |
| Mirae Asset Small Cap Fund Direct-Growth | 149851 | 1.90% | -0.10% | -0.15% | Apr 2025 | |
 Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth | 2994 | 2.18% | 0.10% | 0.19% | Apr 2025 | |
 Tata Nifty MidSmall Healthcare Index Fund Direct - Growth | 16649 | 2.18% | 0.09% | 0.18% | Apr 2025 | |
| Shriram ELSS Tax Saver Fund Direct - Growth | 5800 | 2.12% | 0.07% | 2.12% | Apr 2025 | |
| Shriram Multi Sector Rotation Fund Direct-Growth | 45305 | 4.10% | 0.07% | 2.04% | Apr 2025 | |
| Shriram Flexi Cap Fund Direct - Growth | 15800 | 2.08% | 0.06% | 2.08% | Apr 2025 | |
 Quantum Ethical Fund Direct - Growth | 3225 | 1.11% | -0.06% | -0.05% | Apr 2025 | |
 Nippon India Pharma Fund Direct-Growth | 1426170 | 3.04% | 0.05% | 0.20% | Apr 2025 | |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth | 8427 | 0.93% | 0.05% | 0.93% | Apr 2025 | |
 Axis Small Cap Fund Direct-Growth | 2525796 | 1.91% | 0.03% | 0.17% | Apr 2025 | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 960 | 0.94% | 0.02% | 0.07% | Apr 2025 | |
 Union Active Momentum Fund Direct-Growth | 50339 | 2.11% | 0.02% | 2.11% | Apr 2025 | |
| DSP Multi Asset Allocation Fund Direct - Growth | 119702 | 0.71% | -0.02% | 0.05% | Apr 2025 |
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years,
23 days)
Chairperson NameDEVI PRASAD SHETTY
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
